Treatment: Radiation Therapy (Q38930349)

7 September 2017

1 reference

title

Treatment: Radiation Therapy (English)

1 reference

adaptive radiation therapy

7 September 2017

main subject

0 references

author name string

Sagus Sampath

series ordinal

1

1 reference

7 September 2017

publication date

1 January 2016

1 reference

Cancer Treatment and Research

7 September 2017

published in

1 reference

7 September 2017

volume

170

1 reference

7 September 2017

page(s)

105-118

1 reference

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Concurrent chemoradiotherapy in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Influence of rotational setup error on tumor shift in bony anatomy matching measured with pulmonary point registration in stereotactic body radiotherapy for early lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-40389-2_5

10.1007/978-3-319-40389-2_5

31 March 2020

Identifiers

DOI

1 reference

7 September 2017

1 reference